| 000 | 01453 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516120114.0 | ||
| 264 | 0 | _c20140514 | |
| 008 | 201405s 0 0 eng d | ||
| 022 | _a1476-5365 | ||
| 024 | 7 |
_a10.1038/bmt.2012.199 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRosenzweig, M | |
| 245 | 0 | 0 |
_aLight-chain amyloidosis: SCT, novel agents and beyond. _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cAug 2013 |
||
| 300 |
_a1022-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAmyloidosis _ximmunology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBoronic Acids _xtherapeutic use |
| 650 | 0 | 4 | _aBortezomib |
| 650 | 0 | 4 |
_aDexamethasone _xtherapeutic use |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Light Chains _ximmunology |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aLenalidomide |
| 650 | 0 | 4 |
_aMelphalan _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrazines _xtherapeutic use |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aThalidomide _xanalogs & derivatives |
| 700 | 1 | _aGiralt, S | |
| 700 | 1 | _aLandau, H | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 48 _gno. 8 _gp. 1022-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bmt.2012.199 _zAvailable from publisher's website |
| 999 |
_c22217871 _d22217871 |
||